Quantcast

Latest Pneumococcal conjugate vaccine Stories

2012-01-30 08:12:12

Genetics has provided surprising insights into why vaccines used in both the UK and US to combat serious childhood infections can eventually fail.

2012-01-18 10:44:01

Grant MacKenzie of the MRC Unit in The Gambia and colleagues describe in this week's PLoS Medicine how they set up a population-based surveillance system to assess the impact of pneumococcal conjugate vaccines (PCVs) on invasive pneumococcal disease (IPD) and radiological pneumonia in children in The Gambia.

2011-11-30 14:33:57

Seventy-seven percent of Washington state pediatricians report that they are sometimes or frequently asked to provide alternative childhood vaccine schedules for their patients.

2011-11-10 12:56:38

Vaccines against the primary cause of deaths from pneumonia in developing countries could save millions of lives and are highly cost-effective.

2011-10-19 05:31:58

Vaccinating young children against pneumonia in turn will protect the entire community.

2011-09-22 21:21:26

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a novel type of antibody works against pneumococcal bacteria.

2011-06-15 04:00:00

SCHLIEREN, Switzerland, June 15, 2011 /PRNewswire/ -- GlycoVaxyn AG, a leader in the development of conjugate vaccines, today announced that it will host its Second Annual Science Day to discuss challenges and opportunities in vaccine development on June 16-17, 2011, in Cannes, France.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.